Stories from people navigating gastroesophageal reflux — diagnosis, treatment, caregiving, and the ordinary days in between.
2 stories
Innovation & Devices
The FDA’s Class I classification means gastroenterology and motility services should identify, quarantine and remove affected Bravo CF delivery devices while reviewing scheduled esophageal pH studies.
Rayan Salih · October 14, 2026 · 6 min
Clinical Briefs
The FDA reported 184 serious injuries and no deaths involving specified Medtronic and Given Imaging esophageal pH capsule delivery devices. Gastroenterology services should review inventory, workflows and follow-up.
Rayan Salih · 7 min read
Other conditions
One story a day
One health journey each morning — no advice, no alarm, just company for the road.